Uncategorized
Novel cells, delivery procedure in development for retinal diseases
COPENHAGEN — A novel agent derived from human umbilical tissue and a novel system to deliver the agent suprachoroidally may ultimately benefit patients with retinal disease, according to Christopher Riemann, MD. Riemann explained both the agent and the delivery system at the Euretina meeting.